Prestige Consumer Healthcare (PBH) Competitors

Interparfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap personal products companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

Is IPAR or PBH more profitable?

Prestige Consumer Healthcare has a net margin of 18.86% compared to Interparfums' net margin of 11.30%. Interparfums' return on equity of 17.62% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Interparfums	11.30%	17.62%	11.86%
Prestige Consumer Healthcare	18.86%	12.87%	6.78%

Which has more risk and volatility, IPAR or PBH?

Interparfums has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500.

Do analysts rate IPAR or PBH?

Interparfums currently has a consensus target price of $157.60, indicating a potential upside of 14.69%. Prestige Consumer Healthcare has a consensus target price of $93.33, indicating a potential upside of 16.46%. Given Prestige Consumer Healthcare's higher probable upside, analysts plainly believe Prestige Consumer Healthcare is more favorable than Interparfums.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Interparfums	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Prestige Consumer Healthcare	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Do insiders and institutionals believe in IPAR or PBH?

55.6% of Interparfums shares are owned by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. 43.9% of Interparfums shares are owned by company insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Which has higher earnings & valuation, IPAR or PBH?

Prestige Consumer Healthcare has lower revenue, but higher earnings than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Interparfums	$1.45B	3.04	$164.36M	$5.14	26.73
Prestige Consumer Healthcare	$1.14B	3.48	$214.60M	$4.29	18.68

Does the media prefer IPAR or PBH?

In the previous week, Interparfums had 2 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 6 mentions for Interparfums and 4 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 1.31 beat Interparfums' score of 0.94 indicating that Prestige Consumer Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Interparfums	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Interparfums beats Prestige Consumer Healthcare on 10 of the 16 factors compared between the two stocks.